Cet anticorps anti-MEF2A est un anticorps Souris Monoclonal détectant MEF2A dans ELISA. Adapté pour Humain. Ce Primary Antibody a été cité dans 2+ publications.
MEF2A
Reactivité: Humain, Souris
WB, IHC, ELISA, IF
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
ELISA: 1/10000
Restrictions
For Research Use only
Format
Liquid
Buffer
Purified antibody in PBS with 0.05 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Zhao, Zhao, Peng: "The effects of myocyte enhancer factor 2A gene on the proliferation, migration and phenotype of vascular smooth muscle cells." dans: Cell biochemistry and function, Vol. 30, Issue 2, pp. 108-13, (2012) (PubMed).
Guella, Rimoldi, Asselta, Ardissino, Francolini, Martinelli, Girelli, Peyvandi, Tubaro, Merlini, Mannucci, Duga: "Association and functional analyses of MEF2A as a susceptibility gene for premature myocardial infarction and coronary artery disease." dans: Circulation. Cardiovascular genetics, Vol. 2, Issue 2, pp. 165-72, (2009) (PubMed).
Antigène
MEF2A
(Myocyte Enhancer Factor 2A (MEF2A))
Autre désignation
MEF2A
Sujet
The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.